China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China flag China · Delayed Price · Currency is CNY
18.85
+0.34 (1.84%)
At close: Mar 27, 2026

China Resources Boya Bio-pharmaceutical Group Co.,Ltd Company Description

China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the research, development, production, and sale of blood products in China.

It offers blood products, such as human serum albumin; human, intravenous, freeze-dried intravenous, hepatitis B, tetanus, and rabies immunoglobulin; and human fibrinogen, prothrombin complex, and coagulation factor VIII.

The company also provides compound bone peptide, oxytocin, heparin sodium injection, posterior pituitary, and carboprost tromethamine injection.

In addition, it engages in research, development, production, and sales of anti-infective, diabetes, and cardiovascular drugs.

The company was formerly known as Boya Bio-pharmaceutical Group Co., Ltd. and changed its name to China Resources Boya Bio-pharmaceutical Group Co.,Ltd. The company was founded in 1993 and is based in Fuzhou, China.

China Resources Boya Bio-pharmaceutical Group Co.,Ltd
CountryChina
Founded1993
IndustryBiotechnology
SectorHealthcare
Employees1,938
CEOXiaoming Liang

Contact Details

Address:
No. 333, Huiquan Road
Fuzhou, 344000
China
Phone86 79 4822 4549
Websitechina-boya.com

Stock Details

Ticker Symbol300294
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100001FF1
SIC Code2836

Key Executives

NamePosition
Xiaoming LiangPresident and Director
Huacheng LiangVice President, Chief Financial Officer, Secretary and Director
Hui RenVice President and Director
Bing ChenVice President
Shousun IiVice President
Shuanhong ZhangVice President
Zi He WangAccounting Supervisor
Qian Qian YanCompliance Manager and Employee Representative Supervisor